Janet Dorling
2019
In 2019, Janet Dorling earned a total compensation of $2M as Former Chief Commercial Officer at Cymabay Therapeutics.
Compensation breakdown
| Bonus | $15,000 |
|---|---|
| Option Awards | $1,303,336 |
| Salary | $163,846 |
| Other | $558,870 |
| Total | $2,041,052 |
Dorling received $1.3M in option awards, accounting for 64% of the total pay in 2019.
Dorling also received $15K in bonus, $163.8K in salary and $558.9K in other compensation.
Rankings
In 2019, Janet Dorling's compensation ranked 5,826th out of 13,971 executives tracked by ExecPay. In other words, Dorling earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,826 out of 13,971 | 58th |
Division Manufacturing | 2,182 out of 5,701 | 62nd |
Major group Chemicals And Allied Products | 786 out of 2,200 | 64th |
Industry group Drugs | 662 out of 1,886 | 65th |
Industry Pharmaceutical Preparations | 487 out of 1,398 | 65th |
Source: SEC filing on May 15, 2020.
Dorling's colleagues
We found four more compensation records of executives who worked with Janet Dorling at Cymabay Therapeutics in 2019.